These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9222126)

  • 21. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinogenesis, bioassays, and the regulatory modus operandi.
    Lorentzen RJ
    Toxicol Pathol; 2010 Apr; 38(3):506-7. PubMed ID: 20124497
    [No Abstract]   [Full Text] [Related]  

  • 24. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays.
    Benigni R; Bossa C; Tcheremenskaia O; Giuliani A
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):809-19. PubMed ID: 20438313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Speculations on the rodent carcinogenicity of 30 chemicals currently under evaluation in rat and mouse bioassays organised by the U.S. National Toxicology Program.
    Bootman J
    Environ Mol Mutagen; 1996; 27(3):237-43. PubMed ID: 8625960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental science. NIEHS toxicologist receives a 'gag order'.
    Ferber D
    Science; 2002 Aug; 297(5583):915-6. PubMed ID: 12169702
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of different computerized classification methods for predicting carcinogenicity from short-term test results.
    Benigni R; Pellizzone G; Giuliani A
    J Toxicol Environ Health; 1989; 28(4):427-44. PubMed ID: 2593175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of data from the strain A mouse bioassay with long-term bioassays.
    Maronpot RR
    Exp Lung Res; 1991; 17(2):425-31. PubMed ID: 2050041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement and validation of a medium-term gpt delta rat model for predicting chemical carcinogenicity and underlying mode of action.
    Matsushita K; Kuroda K; Ishii Y; Takasu S; Kijima A; Kawaguchi H; Miyoshi N; Nohmi T; Ogawa K; Nishikawa A; Umemura T
    Exp Toxicol Pathol; 2014 Sep; 66(7):313-21. PubMed ID: 24929978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Researchers exploring faster alternatives to 2-year test for carcinogenicity.
    Schmidt C
    J Natl Cancer Inst; 2006 Feb; 98(4):228-30. PubMed ID: 16478737
    [No Abstract]   [Full Text] [Related]  

  • 33. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity.
    Tennant RW
    Environ Health Perspect; 1991 Dec; 96():47-51. PubMed ID: 1820276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention versus chemophobia: a defence of rodent carcinogenicity tests.
    Infante PF
    Lancet; 1991 Mar; 337(8740):538-40. PubMed ID: 1671901
    [No Abstract]   [Full Text] [Related]  

  • 36. Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals.
    Van Deun K; Van Cauteren H; Vandenberghe J; Canning M; Vanparys P; Coussement W
    Adverse Drug React Toxicol Rev; 1997 Nov; 16(4):215-33. PubMed ID: 9608857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary".
    Long GG
    Toxicol Pathol; 2010 Apr; 38(3):502-5. PubMed ID: 20124495
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution of the uses of rats and mice for assessing carcinogenic risk from chemicals in humans.
    Ward JM
    Asian Pac J Cancer Prev; 2010; 11(1):18. PubMed ID: 20593921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics.
    Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L
    Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.